Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 09/01/23
End: 08/31/26
Due: 08/31/27
Phase: N/A
Priority: Normal
Start: 03/31/17
End: 02/29/20
Due: 02/28/21
Phase: N/A
Priority: Normal
Start: 12/01/22
End: 12/31/25
Due: 12/31/26
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Neoadjuvant Chemotherapy With PD-1 Inhibitors Combined With SIB-IMRT in the Treatment of Locally Advanced Rectal Cancer | NCT06017583 | Yong Zhang,MD | user2@example.com | None | 2023-09-01 | 2026-08-31 | 2027-08-31 | - | - | 2025-07-14 |
| Endostar Combined With Concurrent Chemoradiotherapy For Locally Advanced Cervical Carcinoma | NCT03086681 | Yong Zhang,MD | user2@example.com | None | 2017-03-31 | 2020-02-29 | 2021-02-28 | - | - | 2025-07-14 |
| Tislelizumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer | NCT05588219 | Yong Zhang,MD | user2@example.com | None | 2022-12-01 | 2025-12-31 | 2026-12-31 | - | - | 2025-07-14 |